These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 4147120)
21. [Determination of sulfapyridine levels in serum--a possibility for the control of dose related therapy with sulfasalazine]. Eitner K; Reinicke C; Hippius M Dtsch Z Verdau Stoffwechselkr; 1984; 44(6):282-8. PubMed ID: 6151895 [TBL] [Abstract][Full Text] [Related]
22. Salicylazosulfapyridine and male infertility. Heineman MJ; Dony JM; Rolland R Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):297-303. PubMed ID: 6120861 [TBL] [Abstract][Full Text] [Related]
23. The use of sulfasalazine in the treatment of inflammatory bowel disease. Spector R J Iowa Med Soc; 1983 Jun; 73(6):230-4. PubMed ID: 6135735 [No Abstract] [Full Text] [Related]
24. Therapeutical experiments in ulcerative colitis and Crohn's disease. Nagy G; Prónay G; Ujszászy L Acta Med Hung; 1985; 42(3-4):163-74. PubMed ID: 2869469 [TBL] [Abstract][Full Text] [Related]
25. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine). Franklin JL; Rosenberg HH Gastroenterology; 1973 Apr; 64(4):517-25. PubMed ID: 4144775 [No Abstract] [Full Text] [Related]
26. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid]. Feurle GE; Helmstädter V Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908 [No Abstract] [Full Text] [Related]
27. Observations on the treatment of colitis. Lennard-Jones JE Schweiz Med Wochenschr; 1971 May; 101(20):701-6. PubMed ID: 4397067 [No Abstract] [Full Text] [Related]
28. [Pharmacokinetics of Azulfidine/Salazopyrin in healthy humans and in patients with chronic inflammatory bowel diseases]. Van Hees PA Z Gastroenterol Verh; 1981 Jun; 19():7-14. PubMed ID: 6168136 [No Abstract] [Full Text] [Related]